Access to Global Disease Innovation
7 Pages Posted: 16 Nov 2006
Date Written: November 15, 2006
The pharmaceutical IP system works well in high-income countries able to afford government subsidies and social insurance. It does not work for the poor in low and middle-income countries. For global diseases (Types I and II), innovation is assured by high-income country markets alone, permitting an accommodation for the poor in low and medium-income countries such as a patent buyout or other access programs which support equitable access without damaging optimal innovation incentives.
Keywords: intellectual property, IP, access, innovation, essential medicines, patent, pharmaceutical
Suggested Citation: Suggested Citation